Co-delivery of Doxorubicin and Curcumin with Polypeptide Nanocarrier for Synergistic Lymphoma Therapy

The traditional chemotherapy, including Adriamycin (Doxorubicin, DOX), is widely used and is part of the first-line chemotherapy of invasive B cell lymphoma. DOX is nonselective cytotoxic drug and has many adverse effects, which limit its clinical application in combination with other anti-cancer dr...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Wei, Song, Yuanyuan, Song, Wantong, Liu, Yingmin, Liu, Zhihe, Zhang, Dawei, Tang, Zhaohui, Bai, Ou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217848/
https://www.ncbi.nlm.nih.gov/pubmed/32398729
http://dx.doi.org/10.1038/s41598-020-64828-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217848/
https://www.ncbi.nlm.nih.gov/pubmed/32398729
http://dx.doi.org/10.1038/s41598-020-64828-1

Ejemplares similares